Arabinda Das to Neuroprotective Agents
This is a "connection" page, showing publications Arabinda Das has written about Neuroprotective Agents.
Connection Strength
1.030
-
Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res. 2006 Apr 21; 1084(1):146-57.
Score: 0.210
-
Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res. 2005 Aug 15; 81(4):551-62.
Score: 0.201
-
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016 04 01; 27(3):271-81.
Score: 0.105
-
Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms. J Pineal Res. 2013 Jan; 54(1):58-68.
Score: 0.081
-
Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines. Neurochem Int. 2011 Aug; 59(2):175-84.
Score: 0.075
-
Estrogen receptor agonists and estrogen attenuate TNF-a-induced apoptosis in VSC4.1 motoneurons. J Endocrinol. 2011 Feb; 208(2):171-82.
Score: 0.072
-
Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats. Ann N Y Acad Sci. 2010 Jun; 1199:90-4.
Score: 0.070
-
Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res. 2009 Sep; 47(2):134-142.
Score: 0.066
-
Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res. 2008 May; 44(4):348-57.
Score: 0.059
-
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
Score: 0.027
-
Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats. J Neurochem. 2016 Mar; 136(5):1064-73.
Score: 0.026
-
Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res. 2011 Oct; 36(10):1809-16.
Score: 0.019
-
Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics. 2011 Apr; 8(2):180-6.
Score: 0.019